🎁Capturing Top 10 Ex_dividend: CALM, AMP, ETN, OMF, BX...
1. Which High Ex-dividend Stock (on 4 August ~ 8 August) do You Like the Most?
Be Sure To Check Out the Last Chance to Buy the Top 10 High dividend stocks going to Ex-dividends This Week: many companies like $Cal-Maine(CALM)$ $ and $Ameriprise(AMP)$ showing below are about to give decent dividends into "your pocket".
Editor's notes:
A dividend-paying stock ex-dividend date, or ex-date, is very important to investors. In a nutshell, if you buy a dividend stock before the ex-dividend date, then you will receive the next upcoming dividend payment.
If you purchase the stock on or after the ex-dividend date, you will not receive the dividend. Some investors utilize strategies whereby they will purchase stocks just prior to an ex-dividend date and sell shortly thereafter.
2. YTD25 of the Above 10 Stocks are as Below:
According to 2025 TradingView data, companies like $Cal-Maine(CALM)$ $Eaton Corp PLC(ETN)$ , $OneMain(OMF)$ , $Idacorp(IDA)$ , $Hess Midstream Partners LP(HESM)$ and $Omega Healthcare Investors(OHI)$ saw their stock prices increase, whereas $Ameriprise(AMP)$ , $Blackstone Group LP(BX)$ , $NVE Corp(NVEC)$ , and $Moelis(MC)$ experienced declines.
3. Reply to Win Tiger Coins
Which stock above do you like the most? Why?
Please find the Analyst Price Target of the mentioned stocks from Tiger Trade "Analysis".
Any other companies going to ex_dividend this week you are interested in?
🎁Prizes
🐯 All valid comment on the following post will receive 5 Tiger Coins.
🐯 The Top 3 comments with the most likes will get another 10 Tiger Coins.
For SG users only, a tool to boost your purchasing power and trading ideas with a Cash Boost Account!
Welcome to open a CBA today and enjoy access to a trading limit of up to SGD 20,000 with upcoming 0-commission, unlimited trading on SG, HK, and US stocks, as well as ETFs. Find out more here.
Other helpful links:
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
$Cal-Maine(CALM)$ 🤑📈🚀 Top Ex-Dividend Stocks to Seize This Week: Can CALM Lead the Charge? 🚀📈🤑
🎯 Executive Summary:
I’m extremely confident that Cal-Maine Foods (CALM) stands out as the premier ex-dividend stock to target from August 4–8, 2025. With a robust $2.35 dividend payout looming and an ex-dividend date of August 4, this move aligns with a broader resurgence in consumer staples amid inflationary pressures. The stock’s current price of $111.14 reflects a 2.13% year-to-date (YTD) gain, bolstered by insider buying trends and institutional accumulation, signaling strong conviction. This isn’t merely a dividend play; it’s a strategic entry into a sector poised for stability as macro volatility persists.
💰 Financial Performance Breakdown:
Cal-Maine’s financials underscore its appeal. The company reported Q3 2025 revenue of $1.03 billion, up 8.9% year-over-year (YoY), driven by a 12% increase in egg sales volume. Adjusted EPS hit $1.92, surpassing consensus estimates of $1.85 by 3.8%, while net income rose 15.2% YoY to $445 million. Free cash flow (FCF) strengthened to $320 million, a 10% QoQ improvement, with EBITDA margins expanding to 22.3% from 20.1% last year. Segment growth in specialty eggs contributed 18% to revenue, highlighting diversification success.
🛠️ Strategic Headwinds & Execution Risk:
Despite its strength, Cal-Maine faces risks. Rising feed costs, up 9% YoY due to avian flu disruptions, could compress margins if unmitigated. Regulatory scrutiny over poultry welfare standards poses a compliance challenge; however, management reaffirmed 2025 guidance of $4.50–$4.80 EPS. Overexpansion into new markets risks capex overruns, yet the company’s execution track record, delivering 95% of projects on time, mitigates this concern. Strategic agility will be key.
🧠 Analyst & Institutional Sentiment:
Analyst sentiment leans bullish. Goldman Sachs raised its price target to $125 (implied upside 12.5%) with a Buy rating, while Barclays initiated coverage at $118 (6.2% upside) with an Overweight call. The average target sits at $121.50, with a high of $130 and low of $110, reflecting warming sentiment. ETF inclusion in $XLP (Consumer Staples Select Sector SPDR) boosts visibility, and call/put flow shows a 2:1 call bias. Institutional buying increased 5% QoQ, with 12% insider ownership reinforcing confidence.
📉📈 Technical Setup:
CALM’s chart paints a bullish picture. Support holds at $105 (50DMA), with resistance at $115 (21EMA) recently breached, signaling a breakout. RSI climbs to 68, indicating momentum without overbought conditions (70+). MACD shows a bullish crossover, with the line above the signal at 0.45. A cup-and-handle pattern emerges, targeting $125 (base) and $135 (stretch). Bollinger bands widen, confirming volatility, with the price hugging the upper band, which is often a precursor to sustained upside.
🌍 Macro & Peer Context:
In a macro environment of 4.5% Fed rates and geopolitical supply chain tensions, consumer staples like CALM outperform. Peers such as $HRL (Hormel Foods) and $TSN (Tyson Foods) lag, with HRL down 3.2% YTD and TSN flat, while CALM’s 2.13% gain outpaces the sector’s 1.8% average. ETF rotations favor $XLP, with $500 million inflows last month, reflecting defensive positioning amid uncertainty.
📊 Valuation & Capital Health:
CALM trades at a forward P/E of 18.2x, below the sector’s 20.5x, and a PEG of 1.1, suggesting fair valuation. EV/EBITDA stands at 12.3x versus a peer average of 14x, while price-to-FCF yields 8.2%, attractive for dividend seekers. Cash reserves hit $600 million, with debt at $150 million (CET1 ratio 15%), ensuring robust capital health. Projections estimate EPS growth to $5.00 by Q4 2025.
⚖️ Verdict & Trade Plan:
Buy CALM. Enter at $112–$114, with a stop-loss at $105. Target $125 (base) and $135 (stretch), confirmed by a volume spike above 1.2 million shares or a retest of $115 resistance. Upcoming catalysts include the August 19 payment date and Q4 earnings on September 15, where guidance updates could fuel momentum.
🏁 Conclusion:
This isn’t just a dividend grab. It’s a calculated stake in a company outpacing its peers and navigating macro storms with precision. The market may hesitate, but I see a structural winner emerging.
📌 Key Takeaways:
• Dividend: $2.35, ex-date August 4, payment August 19.
• EPS: $1.92, beat consensus $1.85 by 3.8%.
• Analyst PT: Goldman Sachs $125, Buy; Barclays $118, Overweight.
• YTD: +2.13%, outpacing $HRL (-3.2%) and $TSN (0%).
• Technical: Breakout above $115, RSI 68, MACD bullish crossover.
📢 Don’t miss out! Like, Repost and Follow me for exclusive setups, cutting-edge trends, and insights that move markets 🚀📈 I’m obsessed with hunting down the next big movers and sharing strategies that crush it. Let’s outsmart the market and stack those gains together! 🍀
Trade like a boss! Happy trading ahead, Cheers, BC 📈🚀🍀🍀🍀
@Tiger_Earnings
$Cal-Maine(CALM)$ 🤑📈🚀 Top Ex-Dividend Stocks to Seize This Week: Can CALM Lead the Charge? 🚀📈🤑
🎯 Executive Summary:
I’m extremely confident that Cal-Maine Foods (CALM) stands out as the premier ex-dividend stock to target from August 4–8, 2025. With a robust $2.35 dividend payout looming and an ex-dividend date of August 4, this move aligns with a broader resurgence in consumer staples amid inflationary pressures. The stock’s current price of $111.14 reflects a 2.13% year-to-date (YTD) gain, bolstered by insider buying trends and institutional accumulation, signaling strong conviction. This isn’t merely a dividend play; it’s a strategic entry into a sector poised for stability as macro volatility persists.
💰 Financial Performance Breakdown:
Cal-Maine’s financials underscore its appeal. The company reported Q3 2025 revenue of $1.03 billion, up 8.9% year-over-year (YoY), driven by a 12% increase in egg sales volume. Adjusted EPS hit $1.92, surpassing consensus estimates of $1.85 by 3.8%, while net income rose 15.2% YoY to $445 million. Free cash flow (FCF) strengthened to $320 million, a 10% QoQ improvement, with EBITDA margins expanding to 22.3% from 20.1% last year. Segment growth in specialty eggs contributed 18% to revenue, highlighting diversification success.
🛠️ Strategic Headwinds & Execution Risk:
Despite its strength, Cal-Maine faces risks. Rising feed costs, up 9% YoY due to avian flu disruptions, could compress margins if unmitigated. Regulatory scrutiny over poultry welfare standards poses a compliance challenge; however, management reaffirmed 2025 guidance of $4.50–$4.80 EPS. Overexpansion into new markets risks capex overruns, yet the company’s execution track record, delivering 95% of projects on time, mitigates this concern. Strategic agility will be key.
🧠 Analyst & Institutional Sentiment:
Analyst sentiment leans bullish. Goldman Sachs raised its price target to $125 (implied upside 12.5%) with a Buy rating, while Barclays initiated coverage at $118 (6.2% upside) with an Overweight call. The average target sits at $121.50, with a high of $130 and low of $110, reflecting warming sentiment. ETF inclusion in $XLP (Consumer Staples Select Sector SPDR) boosts visibility, and call/put flow shows a 2:1 call bias. Institutional buying increased 5% QoQ, with 12% insider ownership reinforcing confidence.
📉📈 Technical Setup:
CALM’s chart paints a bullish picture. Support holds at $105 (50DMA), with resistance at $115 (21EMA) recently breached, signaling a breakout. RSI climbs to 68, indicating momentum without overbought conditions (70+). MACD shows a bullish crossover, with the line above the signal at 0.45. A cup-and-handle pattern emerges, targeting $125 (base) and $135 (stretch). Bollinger bands widen, confirming volatility, with the price hugging the upper band, which is often a precursor to sustained upside.
🌍 Macro & Peer Context:
In a macro environment of 4.5% Fed rates and geopolitical supply chain tensions, consumer staples like CALM outperform. Peers such as $HRL (Hormel Foods) and $TSN (Tyson Foods) lag, with HRL down 3.2% YTD and TSN flat, while CALM’s 2.13% gain outpaces the sector’s 1.8% average. ETF rotations favor $XLP, with $500 million inflows last month, reflecting defensive positioning amid uncertainty.
📊 Valuation & Capital Health:
CALM trades at a forward P/E of 18.2x, below the sector’s 20.5x, and a PEG of 1.1, suggesting fair valuation. EV/EBITDA stands at 12.3x versus a peer average of 14x, while price-to-FCF yields 8.2%, attractive for dividend seekers. Cash reserves hit $600 million, with debt at $150 million (CET1 ratio 15%), ensuring robust capital health. Projections estimate EPS growth to $5.00 by Q4 2025.
⚖️ Verdict & Trade Plan:
Buy CALM. Enter at $112–$114, with a stop-loss at $105. Target $125 (base) and $135 (stretch), confirmed by a volume spike above 1.2 million shares or a retest of $115 resistance. Upcoming catalysts include the August 19 payment date and Q4 earnings on September 15, where guidance updates could fuel momentum.
🏁 Conclusion:
This isn’t just a dividend grab. It’s a calculated stake in a company outpacing its peers and navigating macro storms with precision. The market may hesitate, but I see a structural winner emerging.
📌 Key Takeaways:
• Dividend: $2.35, ex-date August 4, payment August 19.
• EPS: $1.92, beat consensus $1.85 by 3.8%.
• Analyst PT: Goldman Sachs $125, Buy; Barclays $118, Overweight.
• YTD: +2.13%, outpacing $HRL (-3.2%) and $TSN (0%).
• Technical: Breakout above $115, RSI 68, MACD bullish crossover.
📢 Don’t miss out! Like, Repost and Follow me for exclusive setups, cutting-edge trends, and insights that move markets 🚀📈 I’m obsessed with hunting down the next big movers and sharing strategies that crush it. Let’s outsmart the market and stack those gains together! 🍀
Trade like a boss! Happy trading ahead, Cheers, BC 📈🚀🍀🍀🍀
@Tiger_Earnings
$Cal-Maine(CALM)$ 🤑📈🚀 Top Ex-Dividend Stocks to Seize This Week: Can CALM Lead the Charge? 🚀📈🤑
🎯 Executive Summary:
I’m extremely confident that Cal-Maine Foods (CALM) stands out as the premier ex-dividend stock to target from August 4–8, 2025. With a robust $2.35 dividend payout looming and an ex-dividend date of August 4, this move aligns with a broader resurgence in consumer staples amid inflationary pressures. The stock’s current price of $111.14 reflects a 2.13% year-to-date (YTD) gain, bolstered by insider buying trends and institutional accumulation, signaling strong conviction. This isn’t merely a dividend play; it’s a strategic entry into a sector poised for stability as macro volatility persists.
💰 Financial Performance Breakdown:
Cal-Maine’s financials underscore its appeal. The company reported Q3 2025 revenue of $1.03 billion, up 8.9% year-over-year (YoY), driven by a 12% increase in egg sales volume. Adjusted EPS hit $1.92, surpassing consensus estimates of $1.85 by 3.8%, while net income rose 15.2% YoY to $445 million. Free cash flow (FCF) strengthened to $320 million, a 10% QoQ improvement, with EBITDA margins expanding to 22.3% from 20.1% last year. Segment growth in specialty eggs contributed 18% to revenue, highlighting diversification success.
🛠️ Strategic Headwinds & Execution Risk:
Despite its strength, Cal-Maine faces risks. Rising feed costs, up 9% YoY due to avian flu disruptions, could compress margins if unmitigated. Regulatory scrutiny over poultry welfare standards poses a compliance challenge; however, management reaffirmed 2025 guidance of $4.50–$4.80 EPS. Overexpansion into new markets risks capex overruns, yet the company’s execution track record, delivering 95% of projects on time, mitigates this concern. Strategic agility will be key.
🧠 Analyst & Institutional Sentiment:
Analyst sentiment leans bullish. Goldman Sachs raised its price target to $125 (implied upside 12.5%) with a Buy rating, while Barclays initiated coverage at $118 (6.2% upside) with an Overweight call. The average target sits at $121.50, with a high of $130 and low of $110, reflecting warming sentiment. ETF inclusion in $XLP (Consumer Staples Select Sector SPDR) boosts visibility, and call/put flow shows a 2:1 call bias. Institutional buying increased 5% QoQ, with 12% insider ownership reinforcing confidence.
📉📈 Technical Setup:
CALM’s chart paints a bullish picture. Support holds at $105 (50DMA), with resistance at $115 (21EMA) recently breached, signaling a breakout. RSI climbs to 68, indicating momentum without overbought conditions (70+). MACD shows a bullish crossover, with the line above the signal at 0.45. A cup-and-handle pattern emerges, targeting $125 (base) and $135 (stretch). Bollinger bands widen, confirming volatility, with the price hugging the upper band, which is often a precursor to sustained upside.
🌍 Macro & Peer Context:
In a macro environment of 4.5% Fed rates and geopolitical supply chain tensions, consumer staples like CALM outperform. Peers such as $HRL (Hormel Foods) and $TSN (Tyson Foods) lag, with HRL down 3.2% YTD and TSN flat, while CALM’s 2.13% gain outpaces the sector’s 1.8% average. ETF rotations favor $XLP, with $500 million inflows last month, reflecting defensive positioning amid uncertainty.
📊 Valuation & Capital Health:
CALM trades at a forward P/E of 18.2x, below the sector’s 20.5x, and a PEG of 1.1, suggesting fair valuation. EV/EBITDA stands at 12.3x versus a peer average of 14x, while price-to-FCF yields 8.2%, attractive for dividend seekers. Cash reserves hit $600 million, with debt at $150 million (CET1 ratio 15%), ensuring robust capital health. Projections estimate EPS growth to $5.00 by Q4 2025.
⚖️ Verdict & Trade Plan:
Buy CALM. Enter at $112–$114, with a stop-loss at $105. Target $125 (base) and $135 (stretch), confirmed by a volume spike above 1.2 million shares or a retest of $115 resistance. Upcoming catalysts include the August 19 payment date and Q4 earnings on September 15, where guidance updates could fuel momentum.
🏁 Conclusion:
This isn’t just a dividend grab. It’s a calculated stake in a company outpacing its peers and navigating macro storms with precision. The market may hesitate, but I see a structural winner emerging.
📌 Key Takeaways:
• Dividend: $2.35, ex-date August 4, payment August 19.
• EPS: $1.92, beat consensus $1.85 by 3.8%.
• Analyst PT: Goldman Sachs $125, Buy; Barclays $118, Overweight.
• YTD: +2.13%, outpacing $HRL (-3.2%) and $TSN (0%).
• Technical: Breakout above $115, RSI 68, MACD bullish crossover.
📢 Don’t miss out! Like, Repost and Follow me for exclusive setups, cutting-edge trends, and insights that move markets 🚀📈 I’m obsessed with hunting down the next big movers and sharing strategies that crush it. Let’s outsmart the market and stack those gains together! 🍀
Trade like a boss! Happy trading ahead, Cheers, BC 📈🚀🍀🍀🍀
@Tiger_Earnings